Advisor Group Holdings, Inc. 180 Life Sciences Corp. Transaction History

Advisor Group Holdings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.12 - $1.31 $24 - $262	-200 Reduced 9.64%	1,875 $1,000
Q1 2022 May 04, 2022	BUY	$2.53 - $3.9 $910 - $1,404	360 Added 20.99%	2,075 $6,000
Q3 2021 Nov 05, 2021	BUY	$5.11 - $10.81 $7,741 - $16,377	1,515 Added 757.5%	1,715 $9,000
Q2 2021 Aug 02, 2021	BUY	$6.7 - $11.98 $1,340 - $2,396	200 New	200 $2,000

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $81.1M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.